tm logo

Monitor this mark

View On USPTO

FAXVERZA
Dead/Abandoned
ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE

failure to respond or late response

on 01 Mar 2024

Last Applicant/ Owned by

Horizon Therapeutics Ireland DAC

70 St. Stephen's Green

Dublin 2

IE

D02E2X4

Serial Number

98081856 filed on 12th Jul 2023

Registration Number

N/A

Correspondent Address

Elsa D. Lemoine

Elsa D. Lemoine Amgen Inc.

Trademark Operations - MS-28-5A

Thousand Oaks, CA 91320-1799

United States

Filing Basis

1. intent to use

2. intent to use current

Disclaimer

NO DATA

FAXVERZA

Providing information featuring health information to patients and healthcare professionals via a website Pharmaceutical preparations

Classification Information

Class [044]
Medical, Beauty & Agricultural Services

Providing information featuring health information to patients and healthcare professionals via a website

First Use Date in General

N/A

First Use Date in Commerce

N/A

Class [005]
Pharmaceutical Products

Pharmaceutical preparations

First Use Date in General

N/A

First Use Date in Commerce

N/A

Mark Details

Serial Number

No 98081856

Mark Type

No Service Mark

Attorney Docket Number

No TM-2283-US-1

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History

Show more

Status DateAction Taken
04th Jun 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
04th Jun 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
04th Jun 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
04th Jun 2024TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
01st Mar 2024ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
01st Mar 2024ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
15th Nov 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
15th Nov 2023NON-FINAL ACTION E-MAILED
15th Nov 2023NON-FINAL ACTION WRITTEN
13th Nov 2023ASSIGNED TO EXAMINER